Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                  to                 

 

Commission File Number 1-5112

 


 

ETHYL CORPORATION

(Exact name of registrant as specified in its charter)

 


 

VIRGINIA   54-0118820

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

330 SOUTH FOURTH STREET    
RICHMOND, VIRGINIA   23218-2189
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code - (804) 788-5000

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Number of shares of common stock, $1 par value, outstanding as of April 30, 2004: 16,883,009.

 



Table of Contents

ETHYL CORPORATION

 

I N D E X

 

     Page
Number


PART I. FINANCIAL INFORMATION

    

ITEM 1. Financial Statements

    

Consolidated Statements of Income - Three Months Ended March 31, 2004 and 2003

   3

Consolidated Balance Sheets – March 31, 2004 and December 31, 2003

   4

Condensed Consolidated Statements of Cash Flows - Three Months Ended March 31, 2004 and 2003

   5

Notes to Financial Statements

   6-21

ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition

   22-31

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

   32

ITEM 4. Controls and Procedures

   32

PART II. OTHER INFORMATION

    

ITEM 1. Legal Proceedings

   33

ITEM 6. Exhibits and Reports on Form 8-K

   33

SIGNATURES

   34

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

 

ETHYL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In thousands except per share amounts)

(Unaudited)

 

     Three Months Ended
March 31


 
     2004

   2003

 

Net sales

   $ 216,770    $ 173,466  

Cost of goods sold

     170,909      137,406  
    

  


Gross profit

     45,861      36,060  

TEL marketing agreements services

     7,312      3,001  

Selling, general, and administrative expenses

     23,518      20,588  

Research, development, and testing expenses

     15,749      13,682  
    

  


Operating profit

     13,906      4,791  

Interest and financing expenses

     5,156      4,802  

Other income (expense), net

     166      (198 )
    

  


Income (loss) from continuing operations before income taxes

     8,916      (209 )

Income tax expense (benefit)

     3,098      (72 )
    

  


Income (loss) from continuing operations

     5,818      (137 )

Discontinued operations

               

Gain on disposal of business (net of tax)

     —        14,805  
    

  


Income before cumulative effect of accounting change

     5,818      14,668  

Cumulative effect of accounting change (net of tax)

     —        1,624  
    

  


Net income

   $ 5,818    $ 16,292  
    

  


Basic earnings per share:

               

Earnings (loss) from continuing operations

   $ 0.35    $ (0.01 )

Discontinued operations (net of tax)

     —        0.89  

Cumulative effect of accounting change (net of tax)

     —        0.10  
    

  


Basic earnings per share

   $ 0.35    $ 0.98  
    

  


Diluted earnings per share:

               

Earnings (loss) from continuing operations

   $ 0.34    $ (0.01 )

Discontinued operations (net of tax)

     —        0.89  

Cumulative effect of accounting change (net of tax)

     —        0.10  
    

  


Diluted earnings per share

   $ 0.34    $ 0.98  
    

  


Shares used to compute basic earnings per share

     16,813      16,689  
    

  


Shares used to compute diluted earnings per share

     17,121      16,689  
    

  


 

See accompanying notes to financial statements.

 

3


Table of Contents

ETHYL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, unaudited)

 

     March 31
2004


    December 31
2003


 
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 22,290     $ 29,052  

Restricted cash

     1,805       1,903  

Trade and other accounts receivable, less allowance for doubtful accounts ($2,691 - 2004; $2,382 - 2003)

     135,948       132,542  

Receivable - TEL marketing agreements services

     2,228       2,456  

Inventories:

                

Finished goods and work-in-process

     101,207       103,734  

Raw materials

     12,757       12,630  

Stores, supplies and other

     8,340       8,064  
    


 


       122,304       124,428  

Prepaid expenses

     9,061       3,810  

Deferred income taxes

     11,001       11,296  
    


 


Total current assets

     304,637       305,487  
    


 


Property, plant and equipment, at cost

     753,420       751,919  

Less accumulated depreciation and amortization

     583,481       577,686  
    


 


Net property, plant and equipment

     169,939       174,233  
    


 


Prepaid pension cost

     22,754       21,829  

Deferred income taxes

     8,527       5,471  

Other assets and deferred charges

     67,069       75,564  

Intangibles, net of amortization

     61,272       62,849  
    


 


Total assets

   $ 634,198     $ 645,433  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 59,300     $ 53,589  

Accrued expenses

     42,345       50,691  

Long-term debt, current portion

     5,871       6,978  

Income taxes payable

     15,657       10,055  
    


 


Total current liabilities

     123,173       121,313  
    


 


Long-term debt

     188,205       201,839  

Other noncurrent liabilities

     117,607       122,598  

Commitments and contingencies (Note 10)

                

Shareholders’ equity

                

Common stock ($1 par value) Issued - 16,831,509 in 2004 and 16,786,009 in 2003

     16,832       16,786  

Additional paid-in capital

     67,242       67,091  

Accumulated other comprehensive loss

     (20,649 )     (20,164 )

Retained earnings

     141,788       135,970  
    


 


       205,213       199,683  
    


 


Total liabilities and shareholders’ equity

   $ 634,198     $ 645,433  
    


 


 

See accompanying notes to financial statements.

 

4


Table of Contents

ETHYL CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

     Three Months Ended
March 31


 
     2004

    2003

 

Cash and cash equivalents at beginning of year

   $ 29,052     $ 15,478  
    


 


Cash flows from operating activities:

                

Net income

     5,818       16,292  

Adjustments to reconcile net income to cash flows from operating activities:

                

Depreciation and other amortization

     10,874       11,271  

Amortization of deferred financing costs

     1,086       1,318  

Noncash pension expense

     2,583       2,316  

Gain on sale of phenolic antioxidant business

     —         (23,196 )

Cumulative effect of accounting change

     —         (2,549 )

Deferred income tax expense

     (2,356 )     2,029  

Working capital changes

     2,789       3,366  

TEL working capital advance

     113       779  

Cash pension contributions

     (5,940 )     (687 )

Proceeds from legal settlement

     —         4,825  

Other, net

     (1,860 )     1,856  
    


 


Cash provided from operating activities

     13,107       17,620  
    


 


Cash flows from investing activities:

                

Capital expenditures

     (3,295 )     (1,818 )

Proceeds from sale of phenolic antioxidant business

     —         27,020  

Other, net

     11       3  
    


 


Cash (used in) provided from investing activities

     (3,284 )     25,205  
    


 


Cash flows from financing activities:

                

Repayment of term loan

     (14,602 )     —    

Repayment of debt - previous agreements

     —         (41,890 )

Debt issuance costs

     —         (1,756 )

Other, net

     58       (131 )
    


 


Cash used in financing activities

     (14,544 )     (43,777 )
    


 


Effect of foreign exchange on cash and cash equivalents

     (2,041 )     1,077  
    


 


Increase (decrease) in cash and cash equivalents

     (6,762 )     125  
    


 


Cash and cash equivalents at end of period

   $ 22,290     $ 15,603  
    


 


 

See accompanying notes to financial statements.

 

5


Table of Contents

ETHYL CORPORATION AND SUBSIDIARIES

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

 

1. In the opinion of management, the accompanying consolidated financial statements of Ethyl Corporation and Subsidiaries contain all necessary adjustments for the fair presentation of, in all material respects, our consolidated financial position as of March 31, 2004, as well as the consolidated results of operations and the consolidated cash flows for the three-months ended March 31, 2004 and 2003. The financial statements are subject to normal year-end adjustments and do not include the comprehensive footnotes. All adjustments are of a normal, recurring nature. These financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report and Form 10-K for the fiscal year ended December 31, 2003 (2003 Annual Report). The results of operations for the three-month period ended March 31, 2004 are not necessarily indicative of the results to be expected for the full year.

 

Unless the context otherwise requires, all references to “we,” “us,” “our,” the “Company,” and “Ethyl” are to Ethyl Corporation and its subsidiaries.

 

2. After approval by the Board of Directors in December 2002, on January 21, 2003, we completed the sale of our phenolic antioxidant business to Albemarle Corporation. Following an extensive assessment, we concluded this business was not part of our future core business or growth goals.

 

As part of the transaction, we sold accounts receivable and inventory, as well as fixed assets at our Orangeburg, South Carolina facility. The net book value of the fixed assets was zero.

 

We recognized a gain of $23.2 million ($14.8 million after tax) in first quarter 2003 related to this transaction.

 

3. The cumulative effect of accounting change in the first quarter 2003 reflects the gain of $2.5 million ($1.6 million after tax or $.10 per share) recognized upon the January 1, 2003 adoption of Statement of Financial Accounting Standard (SFAS) No. 143, “Accounting for Asset Retirement Obligations.” This statement addresses the obligations and asset retirement costs associated with the retirement of tangible long-lived assets. It requires that the fair value of the liability for an asset retirement obligation be recorded when incurred instead of over the life of the asset. The asset retirement costs must be capitalized as part of the carrying value of the long-lived asset. If the liability is settled for an amount other than the recorded balance, either a gain or loss will be recognized at settlement.

 

Our asset retirement obligations are related primarily to TEL operations. These obligations had been previously fully reserved. Upon the implementation of SFAS No. 143 on January 1, 2003, these accruals were discounted to their net present value to comply with the requirements of SFAS No. 143, which resulted in the recognition of a gain. Current accretion of the asset retirement obligations is being expensed in operations. The following table illustrates the activity associated with SFAS No. 143.

 

6


Table of Contents
     March 31
2004


    December 31
2003


 
     (in thousands)  

Asset retirement obligation, beginning of period

   $ 13,238     $ 14,828  

Gain upon implementation of SFAS No. 143

     —         (2,549 )

Accretion expense

     239       575  

Liabilities settled

     (178 )     (884 )

Foreign currency impact

     —         1,268  
    


 


Asset retirement obligation, end of period

   $ 13,299     $